Publication | Closed Access

Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults

VaccinationVaccine SafetyCross-protectionVaccinologyDose-escalation StudyVaccine DevelopmentImmunologyInfection ControlBacillus AnthracisPolyvalent VaccineMedicineVaccine ResearchPhase 1